Return to ads
All categories


Posted by
Posting ads for 49 years
By Wallace Witkowski DNDN SAN FRANCISCO (MarketWatch) -- Shares of Dendreon Corp.

/quotes/comstock/15*!dndn/quotes/nls/dndn (DNDN 50.18, +10.56, +26.65%) jumped Thursday following the Food and Drug Administration's approval of the biotech's drug Provenge to treat advanced prostate cancer..

Reply to this ad
Recently viewed ads
Saved ads
Please log in to browse your saved adverts or sign up if you don't have an account yet.
Popular Stuff